Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

NCT00764907 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: leucovorin calcium
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: prednisone
DRUG: thioguanine
DRUG: vincristine sulfate
DRUG: vindesine

Sponsor

University Hospital, Motol